CN117256708A - Polygonatum sibiricum and wolfberry tea and preparation method thereof - Google Patents
Polygonatum sibiricum and wolfberry tea and preparation method thereof Download PDFInfo
- Publication number
- CN117256708A CN117256708A CN202311331877.4A CN202311331877A CN117256708A CN 117256708 A CN117256708 A CN 117256708A CN 202311331877 A CN202311331877 A CN 202311331877A CN 117256708 A CN117256708 A CN 117256708A
- Authority
- CN
- China
- Prior art keywords
- medlar
- sealwort
- orange peel
- rhizoma polygonati
- dried orange
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 241000037831 Polygonatum sibiricum Species 0.000 title claims description 8
- 235000015459 Lycium barbarum Nutrition 0.000 title claims description 5
- 244000241838 Lycium barbarum Species 0.000 title claims description 3
- 244000269722 Thea sinensis Species 0.000 title abstract 8
- 235000015468 Lycium chinense Nutrition 0.000 title description 6
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 128
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 128
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 128
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 128
- 241000233779 Cyclocarya paliurus Species 0.000 claims abstract description 78
- 235000006533 astragalus Nutrition 0.000 claims abstract description 66
- 235000013305 food Nutrition 0.000 claims abstract description 49
- 239000009636 Huang Qi Substances 0.000 claims abstract description 39
- 239000002131 composite material Substances 0.000 claims abstract description 37
- 229960002413 ferric citrate Drugs 0.000 claims abstract description 34
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 claims abstract description 34
- 239000001508 potassium citrate Substances 0.000 claims abstract description 33
- 229960002635 potassium citrate Drugs 0.000 claims abstract description 33
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims abstract description 33
- 235000011082 potassium citrates Nutrition 0.000 claims abstract description 33
- 241001061264 Astragalus Species 0.000 claims abstract description 32
- 210000004233 talus Anatomy 0.000 claims abstract description 32
- 241001404789 Smilax glabra Species 0.000 claims abstract description 28
- 239000000284 extract Substances 0.000 claims abstract description 26
- 238000010298 pulverizing process Methods 0.000 claims abstract 2
- 241001122767 Theaceae Species 0.000 claims description 68
- 239000000843 powder Substances 0.000 claims description 32
- 239000000706 filtrate Substances 0.000 claims description 30
- 240000009022 Smilax rotundifolia Species 0.000 claims description 26
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 238000002156 mixing Methods 0.000 claims description 23
- 238000001035 drying Methods 0.000 claims description 22
- 238000009835 boiling Methods 0.000 claims description 19
- 150000001875 compounds Chemical class 0.000 claims description 15
- 238000007602 hot air drying Methods 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 238000004806 packaging method and process Methods 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 13
- 238000005303 weighing Methods 0.000 claims description 13
- 229910001220 stainless steel Inorganic materials 0.000 claims description 12
- 239000010935 stainless steel Substances 0.000 claims description 12
- 238000001291 vacuum drying Methods 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 9
- 239000004744 fabric Substances 0.000 claims description 9
- 238000005507 spraying Methods 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 17
- 235000015097 nutrients Nutrition 0.000 abstract description 5
- 241000045403 Astragalus propinquus Species 0.000 description 34
- 239000008280 blood Substances 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 201000005569 Gout Diseases 0.000 description 14
- 230000036772 blood pressure Effects 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- 206010020772 Hypertension Diseases 0.000 description 11
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 11
- 229940116269 uric acid Drugs 0.000 description 11
- 238000001914 filtration Methods 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 235000016709 nutrition Nutrition 0.000 description 9
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 208000031226 Hyperlipidaemia Diseases 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 230000000474 nursing effect Effects 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- 208000024172 Cardiovascular disease Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 201000001421 hyperglycemia Diseases 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 244000241872 Lycium chinense Species 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000035622 drinking Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 201000001431 Hyperuricemia Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000011775 arteriosclerosis disease Diseases 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000009911 Urinary Calculi Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 230000035487 diastolic blood pressure Effects 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000007721 medicinal effect Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000035488 systolic blood pressure Effects 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000015924 Lithiasis Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000007937 eating Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000006174 pH buffer Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 150000007968 uric acids Chemical class 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 102000007592 Apolipoproteins Human genes 0.000 description 1
- 108010071619 Apolipoproteins Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000019025 Hypokalemia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028665 Myxoedema Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038372 Renal arteriosclerosis Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 244000261559 Smilax china Species 0.000 description 1
- 235000000485 Smilax china Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 230000003355 alkalizing urine Effects 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002529 benzbromarone Drugs 0.000 description 1
- WHQCHUCQKNIQEC-UHFFFAOYSA-N benzbromarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(Br)=C(O)C(Br)=C1 WHQCHUCQKNIQEC-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000007211 cardiovascular event Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000007213 cerebrovascular event Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000001513 elbow Anatomy 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000003086 food stabiliser Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 210000001255 hallux Anatomy 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 208000024896 potassium deficiency disease Diseases 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 229960003081 probenecid Drugs 0.000 description 1
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 208000016839 purine metabolism disease Diseases 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 206010038464 renal hypertension Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 208000008281 urolithiasis Diseases 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a sealwort medlar tea and a preparation method thereof, wherein the sealwort medlar tea is prepared from the following raw materials: rhizoma Polygonati and fructus Lycii tea comprises rhizoma Polygonati, ramulus Salicis Babylonicae, potassium citrate, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, ferric citrate, and rhizoma Smilacis Glabrae. The preparation method of the sealwort medlar tea comprises the following steps: step 1: preparing 0.3-3 mm rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, and rhizoma Smilacis Glabrae, and pulverizing; step 2: preparing concentrated extract of rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae with size of less than 0.3 mm; step 3: preparing a composite solution of rhizoma polygonati, cyclocarya paliurus, potassium citrate, dried orange peel, astragalus, medlar, ferric citrate and smilax glabra; step 4: preparing rhizoma polygonati and medlar tea. The invention also discloses the sealwort medlar tea which can be used for food recuperation of four highs and is nutrient and healthy sealwort medlar tea which utilizes the food recuperation.
Description
Technical Field
The invention relates to a sealwort medlar tea and a preparation method thereof, in particular to a sealwort medlar tea, a health tea capable of being used for food recuperation of four highs, and a nutrient and healthy sealwort medlar tea which is prepared by using food.
Background
Four highs
"four-high" generally refers to hypertension, hyperglycemia, hyperlipidemia, and hyperuricemia.
Along with the improvement of the living standard of modern people, the four diseases are all metabolic related diseases and have great relation with life style. Hypertension and hyperglycemia, including elevated blood lipids and uric acid, are associated with irregular diets or too much food containing oils, sugars or purines, so to avoid these four high levels, a healthy diet with low salt, low fat and low purine is usually required.
Hypertension of the type
(hypertension) is a clinical syndrome characterized by an increase in systemic arterial blood pressure (systolic and/or diastolic blood pressure) (systolic pressure. Gtoreq.140 mmHg, diastolic pressure. Gtoreq.90 mmHg) and accompanied by functional or organic impairment of organs such as heart, brain, kidneys, etc. Hypertension is the most common chronic disease and is also the most important risk factor for cardiovascular and cerebrovascular diseases. The blood pressure of normal people fluctuates within a certain range along with the internal and external environment changes. In the whole population, the blood pressure level gradually increases with age to make the systolic blood pressure more obvious, but the diastolic blood pressure after 50 years of age shows a decreasing trend, and the pulse pressure also increases. In recent years, people have a deep understanding of the effects of multiple risk factors of cardiovascular diseases and the protection of heart, brain and kidney target organs, and the diagnosis standard of hypertension is continuously regulated, so that patients with the same blood pressure level are considered to have different risks of cardiovascular diseases, and therefore, the concept of blood pressure stratification is provided, namely, patients with different risks of cardiovascular diseases are suitable for different blood pressure levels. The blood pressure value and risk factor evaluation are the main basis for diagnosing and formulating a hypertension treatment scheme, targets of hypertension management of different patients are different, and doctors face patients on the basis of reference standards, judge the most suitable blood pressure range of the patients according to specific conditions, and adopt targeted treatment measures. Based on improving life style, it is recommended to use long-term antihypertensive drugs for controlling blood pressure within 24 hours. In addition to assessing office blood pressure, patients should also be careful about home early morning blood pressure monitoring and management to control blood pressure and reduce the incidence of cardiovascular and cerebrovascular events.
Hyperglycemia of the blood
The blood sugar value is higher than the normal range, namely hyperglycemia. Hyperglycemia is also commonly known as one of the "four high" states. In addition, "three highs" are hypertension, hyperlipidemia and hyperuricemia, respectively. The normal value of fasting blood glucose is 6.1mmol/L or less, and the normal value of blood glucose after two hours after meal is 7.8mmol/L or less, and if it is higher than this range, it is called hyperglycemia.
Under normal conditions, the human body can ensure that the source and the way of blood sugar are kept balanced through two large regulating systems, namely hormone regulation and nerve regulation, so that the blood sugar is maintained at a certain level. However, under the combined action of genetic factors (such as family history of diabetes) and environmental factors (such as unreasonable diet, obesity, etc.), the two major regulatory functions are disturbed, and rise of blood glucose level occurs.
Hyperlipidemia
Hyperlipidemia refers to a condition of high blood lipid level, which can directly cause some diseases seriously harming human health, such as atherosclerosis, coronary heart disease, pancreatitis, etc.
Cause of hyperlipidemia
Hyperlipidemia can be classified into primary and secondary. Primary is related to congenital and genetic, either due to single or multiple gene defects, abnormalities in receptors, enzymes or apolipoproteins involved in lipoprotein transport and metabolism, or due to environmental factors (diet, nutrition, drugs) and by unknown mechanisms. Secondary to metabolic disorders (diabetes, hypertension, myxoedema, hypothyroidism, obesity, liver and kidney diseases, adrenocortical hyperactivity) or other factors of age, sex, season, drinking, smoking, eating, physical activity, mental stress, emotional activity, etc.
Hyperuricemia-gout
Gout is a group of diseases caused by purine metabolic disturbance, the course of the disease is long, and clinical manifestations can be divided into three phases:
(1) asymptomatic phase:
many patients have hyperuricemia before symptoms occur, and the concentration of blood uric acid is above 7 mg/100 ml. Many patients have no clinical symptoms, and only a few patients have the symptoms of gout.
(2) Acute arthritis phase:
in the sudden onset of the disease, most patients feel joint pain at night and half of the process, and are awakened with systemic symptoms such as fever. The most pain is the hallux and plantar digits first, and the other joints of the hand, wrist, knee, elbow and foot second. After several hours of onset, localized redness, swelling, fever, tenderness and limited movement occur. Without treatment, the fire symptoms self-subside within 3-10 days. And then repeatedly attacks after months or years. The primary is easy to misdiagnose, and a plurality of patients can not pay attention to the treatment of arthritis for a long time until the chronic stage is shifted to, and joint deformity stiffness or heart and kidney serious complications occur.
(3) Chronic arthritis phase:
when the disease progresses, sodium urate is gradually deposited in joints, the attack is gradually frequent, the intermittent period is shortened, the joints are involved and increased, and inflammation enters a chronic stage and cannot completely disappear, the joints start to be deformed and stiff, the joints and kidneys have tophus deposition, urinary tract stones, renal failure, hypertension, arteriosclerosis and the like.
Gout is not joint pain caused by wind-cold. Gout and rheumatoid arthritis are two different diseases. Gout is a disease caused by metabolic disorder, has familial heredity, and is mainly caused by purine metabolism disorder in protein, so that the content of uric acid in blood is increased, and uric acid salt is deposited in tissues such as joints, soft tissues, cartilage, kidneys and the like when reaching a certain concentration, thereby generating various clinical symptoms.
Gout occurs in middle-aged or elderly people of 30-40 years, and is usually manifested by severe pain in the joint due to the onset of symptoms and the sudden onset of symptoms. The middle-aged and elderly people with obesity have sudden joint pain, should be warned about gout, and should be checked in time in hospitals. If the increase of the uric acid level (more than 6 mg%) is detected or the red and swollen part is sucked to find the crystallization of the uric acid salt, the diagnosis of gout is determined.
For gout, it has the main medical treatment and dietotherapy
Drug treatment
The acute onset period of gout is mainly treated by anti-infection, and can relieve acute inflammation and pain. Mainly using non-steroidal anti-inflammatory drugs, glucocorticoids, colchicine and the like. And for the treatment of chronic gout patients, mainly comprises uric acid reduction treatment and anti-inflammatory treatment. The main medicines for uric acid reducing treatment include allopurinol, probenecid, benzbromarone and the like. The main medicines for anti-infection treatment are colchicine and nonsteroidal anti-inflammatory drugs.
The current diet therapy method is less; dietetic therapy mainly aims at reducing consumption of high purine foods, high lipid foods, etc. The more purine content in the human body, the more uric acid is produced by metabolism, and at the same time, the uric acid is produced by alcohol stimulation to the liver, and the incidence rate of gout and the harm of gout to the human body are increased.
At present, food materials are rarely adopted for processing at home and abroad, and the polygonatum sibiricum medlar tea can be used for food nursing of four highs and is nutritional and healthy by utilizing the food nursing.
Disclosure of Invention
The invention relates to a sealwort medlar tea and a preparation method thereof, in particular to a sealwort medlar tea, a health tea capable of being used for food recuperation of four highs, and a nutrient and healthy sealwort medlar tea which is prepared by using food.
In order to achieve the above purpose, the invention provides a sealwort medlar tea, a sealwort medlar tea which can be used for food nursing of four highs and is nutrient and healthy by using the food nursing; the rhizoma polygonati and medlar tea raw materials comprise: rhizoma Polygonati, ramulus et folium Tamaricis, potassium citrate, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, ferric citrate, and rhizoma Smilacis Glabrae.
The polygonatum sibiricum medlar tea can be used for food recuperation of four highs, and is nutritional and healthy, and among the raw materials of the polygonatum sibiricum medlar tea, the cyclocarya paliurus is preferably selected from the group consisting of the mountain of Hunan Zhang Jiangshan, and the polygonatum sibiricum is preferably selected from the group consisting of the mountain of Guibei Gaoshan and Jiuhua mountain.
The sealwort medlar tea can be used for food recuperation of four highs, and is nutritional and healthy, and the sealwort medlar tea is prepared from the following raw materials in proportion: 9% of rhizoma polygonati, 33% of cyclocarya paliurus, 4.5% of potassium citrate, 26% of dried orange peel, 8.5% of astragalus, 9% of medlar, 0.5% of ferric citrate and 9.5% of rhizoma smilacis glabrae.
The invention also provides the sealwort medlar tea, which can be used for food recuperation of four highs and is nutritional and healthy by utilizing the food recuperation, and belongs to the sealwort medlar tea which can be brewed with boiling water for drinking or boiled water for drinking.
The invention also provides a sealwort medlar tea, a food for nursing four highs, a nutrient and healthy sealwort medlar tea which is prepared by using the food, and the preparation method comprises the following steps:
step 1: preparing 0.3-2mm rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, and rhizoma Smilacis Glabrae composite powder
Screening and weighing clean rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae, sterilizing with hot air drying facility, hot air drying, and crushing with stainless steel crusher to obtain 0.3-2mm rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae composite powder, and mixing with rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae composite powder below 0.3 mm;
step 2: preparing concentrated extract of rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, and rhizoma Smilacis Glabrae with size of less than 0.3mm
Placing the crushed composite powder of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus, medlar and smilax glabra obtained in the step 1 into a cloth bag, and extracting at room temperature or heating to obtain extract of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus, medlar and smilax glabra with the size of less than 0.3mm, and concentrating the extract in vacuum to obtain concentrated extract of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus, medlar and smilax glabra;
step 3: preparing composite solution of ferric citrate, potassium citrate, rhizoma Polygonati, ramulus et folium Desmodii Styracifolii, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae
Weighing ferric citrate and potassium citrate, adding the concentrated extract of rhizoma polygonati, cyclocarya paliurus, dried orange peel, radix astragali, medlar and rhizoma smilacis glabrae which are prepared in the step 2 and below 0.3mm, and boiling and dissolving uniformly to obtain a ferric citrate, potassium citrate, rhizoma polygonati, cyclocarya paliurus, dried orange peel, radix astragali, medlar and rhizoma smilacis glabrae composite solution;
step 4: preparation of rhizoma polygonati and medlar tea
Adding the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus, medlar and glabrous greenbrier rhizome prepared in the step 1 into a clean container or mixing equipment, uniformly spraying the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus, medlar and glabrous greenbrier rhizome prepared in the step 3 into the compound solution of ferric citrate, potassium citrate, sealwort, cyclocarya paliurus, dried orange peel, astragalus, medlar and glabrous greenbrier rhizome prepared in the step 1, fully and uniformly mixing, and carrying out vacuum drying or hot air drying; packaging into 6-10 g of heat-sealed food-grade tea bag and food packaging bag, and soaking with boiling water or boiling water to obtain rhizoma Polygonati and fructus Lycii tea.
The polygonatum sibiricum medlar tea provided by the invention can be used for food nursing of four highs, and is nutritional and healthy by utilizing the food nursing.
The invention provides a sealwort medlar tea which can be used for food conditioning of four highs and is nutritional and healthy by utilizing food, and the sealwort medlar tea comprises the following raw materials: rhizoma Polygonati, ramulus et folium Tamaricis, potassium citrate, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, ferric citrate, and rhizoma Smilacis Glabrae.
Preferably, in the above-mentioned ingredients of the sealwort medlar tea, the sealwort is preferably a mountain sealwort or a mountain sealwort of the northern osmanthus, and the cyclocarya paliurus is preferably a mountain cyclocarya paliurus of the Zhangjiujiujiujiujiujiujiu.
Preferably, in the above-mentioned ingredients of the sealwort medlar tea, the sealwort is preferably a northern-osmanthus high mountain sealwort or a Jiuhuashan sealwort. Polygonatum is a lily plant, collected in Tao Hongjing, ming Yi Bie Lu, listed as top grade, li Zhen is considered as a medicine for taking food, so it is also called Cactus food. The rhizoma polygonati has the functions of tonifying middle-jiao qi, strengthening bones and muscles, reducing blood pressure, enhancing human immunity, tonifying kidney, reducing blood, preventing arteriosclerosis and promoting insulin activity, and can be used for treating weakness of spleen and stomach, tiredness and hypodynamia, dry mouth and eating less, lung deficiency and dry cough, essence and blood deficiency, internal heat and diabetes and the like. Rhizoma Polygonati contains multiple nutritional components including sugar, fat, protein, starch, carotene, vitamins, etc., and can be eaten raw or stewed for allaying hunger and building body.
Preferably, in the sealwort medlar tea ingredient, the cyclocarya paliurus is generally called cyclocarya paliurus, the cyclocarya paliurus and the like, and the cyclocarya paliurus grows in deep mountain, is a newly discovered excellent and rare tree species, has a strong medical effect, can treat cardiovascular and cerebrovascular diseases such as arteriosclerosis, diabetes and the like, and has a good curative effect.
The tree leaves have strong medical effect, can treat cardiovascular and cerebrovascular diseases such as arteriosclerosis, diabetes, hypertension, hyperlipidemia, coronary heart disease, cerebral apoplexy and the like, and have good curative effect.
Qian Hui Jiu Suo has the actions of clearing heat, quenching thirst and removing toxicity. Modern scientific experiments find that the cyclocarya paliurus leaves contain a plurality of important medicinal components such as polysaccharide, triterpene, saponin, flavone and the like, and simultaneously detect a plurality of precious microelements such as amino acid, vitamin, germanium, selenium, chromium, vanadium, zinc, iron, calcium and the like. Can enhance the immunity of human bodies, resist oxidation and aging, and is suitable for people suffering from modern three-high chronic diseases to drink. The product has effects of lowering blood pressure, lowering blood sugar, reducing blood lipid, enhancing immunity, resisting oxidation and aging, and protecting liver and fatty liver, and especially has significant blood sugar lowering effect for diabetic people.
Preferably, in the above-mentioned sealwort matrimony vine tea ingredient, the dried orange peel is the dried ripe pericarp of the rutaceae plant orange and its cultivar; picking ripe fruits, peeling peel, and sun drying or low temperature drying. Bitter and pungent taste and warm nature; enter lung and spleen meridians; has the effects of regulating qi, strengthening spleen, eliminating dampness and resolving phlegm; is mainly used for treating abdominal distention, anorexia, vomiting and diarrhea, cough and excessive phlegm; it is combined with Zhu and Hou Po for treating spleen and stomach qi stagnation due to middle energizer cold-dampness, and indicated for abdominal distention and pain, nausea and vomiting, and diarrhea.
Preferably, in the sealwort medlar tea ingredient, the astragalus has the effects of strengthening spleen and tonifying middle-jiao, raising yang and lifting sinking, tonifying defensive and consolidating superficial resistance, promoting urination, and expelling toxin and promoting granulation. It is indicated for spleen qi deficiency, lung qi deficiency, spontaneous perspiration due to qi deficiency, qi and blood deficiency, and sores and ulcers, or chronic ulcer.
Astragalus root is sweet in taste and slightly warm in nature; enter spleen and lung meridians.
Preferably, in the above-mentioned rhizoma Polygonati-fructus Lycii tea ingredient, the rhizoma Smilacis Glabrae is dried rhizome of light She chinaroot greenbrier of Liliaceae, which is perennial evergreen climbing shrubs, and is produced on hillside or under forest. The drug-taking part only selects dried rhizome. Digging in summer and autumn, removing fibrous root, cleaning, and drying to obtain medicine; or slicing, drying, and adding into medicine. Rhizoma smilacis glabrae is sweet and light in taste and neutral in nature. Has the effects of removing toxic substances, removing dampness, and promoting joint function.
Preferably, in the sealwort medlar tea ingredient, medlar is sweet, flat, moist and mainly enters liver and kidney, can tonify kidney and essence, and also can nourish liver and improve vision, and is a good nourishing product. "Lycium chinense" is a famous nourishing plant with the functions of nourishing yin and blood, replenishing vital essence and improving eyesight, and "Shennong Ben Cao Jing" is called "old clothes for strengthening tendons and bones, losing weight, not being old, cold-resistant and summer-heat". The drug theory is that the medicine can tonify deficiency of vital essence and energy, improve eyesight and tranquilize mind, and make people longevity. The traditional Chinese medicine is used for treating soreness and weakness of waist and knees, dizziness, tinnitus and the like caused by deficiency of liver and kidney and deficiency of essence and blood.
The medlar is sweet and flat, moist and is a good nourishing product, which mainly enters the liver and kidney, can tonify the kidney and strengthen essence, and nourish the liver and improve vision.
The medlar is a plant with strong vitality and energy, and is very suitable for eliminating fatigue. It has effects in promoting blood circulation, preventing arteriosclerosis, and preventing fat accumulation in liver; in addition, various vitamins, essential amino acids and linoleic acid contained in the medlar can comprehensively operate, so that metabolism in the body can be promoted, and aging can be prevented.
The Chinese wolfberry has wide medicinal effect, has the curative effects of relieving fever, treating diabetes, relieving cough, reducing sputum and the like, and can reduce blood pressure after the Chinese wolfberry root is decocted for drinking: the wolfberry tea has the functions of treating physique deficiency-cold, sexual cold sensation, stomach strengthening, liver and kidney diseases, phthisis, constipation, insomnia, hypotension, anemia, various eye diseases, hair loss, stomatitis, skin care and the like.
Preferably, in the above-mentioned sealwort medlar tea ingredient, the Ferric citrate (Ferric citrate) is also called as a Ferric citrate, and an inorganic compound. Is edible citrate. Are commonly used as sour agents.
The ferric citrate has effects of strengthening body constitution and relieving fatigue. Can promote fat decomposition and regulate acid-base balance of human body. Relieving infantile anorexia, monophagia, thin hair, mental retardation, late teeth emergence, teenager vigor, fatigue, soreness of waist, backache, hypoimmunity, dental caries, and dental dysplasia. Preventing senile dermatoses, lumbar vertebra and cervical vertebra pain, peptic ulcer, insomnia, dreaminess, palpitation, dysphoria, irritability, anemia, dizziness, arthralgia, and cramp of pregnant woman in lactation period.
Ferric citrate is commonly used in the food science field as a food iron fortifier, nutritional supplement, and the like.
Preferably, in the above-mentioned sealwort medlar tea ingredient, the potassium citrate is a citrate (acidity regulator) with a chemical formula of C6H5K3O7, a molecular weight of 306.39500, and white, slightly hygroscopic crystalline powder. Has no odor, normal saline taste, easy water dissolution, slow dissolution in glycerol, no dissolution in alcohol, salty taste and cool taste. As a stabilizer, a pH buffer, etc. Can be used for various foods, and can be used in proper amount according to production requirements. It can be used for controlling uric acid or cystine from kidney stones, and for preventing and treating hypokalemia and alkalizing urine.
The research shows that the acid-base value and the citric acid value in urine have a very close relation with the formation of urinary tract stones, and the potassium citrate which is a medicine for preventing the urinary stones is most commonly used at present. In acidic urine (pH < 5.5), the solubility of uric acid is extremely low, easily causing uric acid stones; in alkaline urine (pH > 7), however, calcium or magnesium phosphate stones are very easily formed. 63% of the patients with lithangiuria have lower than normal citric acid in urine, while potassium citrate can provide a large amount of citric acid to raise the pH value in urine, so the composition has very remarkable treatment effect on lithangiuria, calcium hypocitrate lithiasis and calcium lithiasis caused by renal tubular poisoning.
Potassium citrate is widely used in various foods as a food stabilizer and pH buffer (acidity regulator).
The raw materials of the sealwort medlar tea are preferably wild raw materials, the raw materials are selected from the wild raw materials, and the raw materials can be selected from artificially planted raw materials or other raw materials with equal and approximate effects under the condition of disallowing conditions.
Detailed Description
The following description of the principles and features of the present invention is provided merely to illustrate the invention and is not intended to limit the invention.
The following describes specific embodiments of the present invention.
Example 1
Step 1: preparing 0.3-2mm rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, and rhizoma Smilacis Glabrae composite powder
Screening and weighing 1.8kg of clean rhizoma polygonati, 6.6kg of cyclocarya paliurus, 5.2kg of dried orange peel, 1.7kg of astragalus membranaceus, 1.8kg of medlar and 1.9kg of rhizoma smilacis glabrae, sterilizing at the temperature of 100 ℃ for 30 minutes in a hot air drying facility, adjusting the drying temperature to 76 ℃ for hot air drying, cooling after drying, crushing by a stainless steel crusher to obtain 0.3-2mm of compound powder of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and rhizoma smilacis glabrae, and carrying out compound crushing with the compound powder of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and rhizoma smilacis glabrae below 0.3 mm.
Step 2: preparing concentrated extract of rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, and rhizoma Smilacis Glabrae with size of less than 0.3mm
Placing 0.95kg of the composite powder of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus, medlar and glabrous greenbrier rhizome which are obtained by crushing in the step 1 into a cloth bag, placing into an extraction tank, adding 5.7kg of food water, extracting for 2 hours at the water temperature of 70 ℃, and filtering for the first time to obtain a first filtrate and a first filter residue; placing the first filter residue and the second filter residue into an extraction tank, adding 5.7kg of food water, extracting at 70deg.C for 2.5 hr, and filtering for the second time to obtain a second filtrate and a second filter residue; placing the second filter residue into an extraction tank, adding 5.7kg of food water, extracting at 70deg.C for 3 hr, and filtering for the third time to obtain the third filtrate.
Mixing the first filtrate, the second filtrate and the third filtrate, adding into a vacuum concentration tank, vacuum concentrating under vacuum concentration pressure of-0.091 MPa at 51deg.C, vacuum concentrating the filtrate until the concentration of the filtrate is about 16 with refractometer to obtain concentrated extract of rhizoma Polygonati, ramulus Salicis Babylonicae, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae.
Step 3: preparing composite solution of ferric citrate, potassium citrate, rhizoma Polygonati, ramulus et folium Desmodii Styracifolii, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae
Weighing 0.1kg of ferric citrate and 0.9kg of potassium citrate, adding the concentrated extract of the sealwort, the cyclocarya paliurus, the dried orange peel, the astragalus membranaceus, the medlar and the glabrous greenbrier rhizome which are prepared in the step 2 and below 0.3mm, and boiling and dissolving uniformly to obtain the ferric citrate, potassium citrate, sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and glabrous greenbrier rhizome composite solution.
Step 4: preparation of rhizoma polygonati and medlar tea
Adding the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and smilax glabra prepared in the step 1 into a clean container or mixing equipment, uniformly spraying the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and smilax glabra prepared in the step 3 into the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and smilax glabra prepared in the step 1, fully and uniformly mixing, adding a 33cm multiplied by 57cm stainless steel plate of a vacuum drying oven, 2.5kg of each plate, vacuum pressure of-0.092 MPa and temperature of 53 ℃, vacuum drying, cooling after drying, packaging into heat-sealing food-grade tea bags and food packaging bags, and obtaining 6 g of each sealwort medlar tea which can be drunk by boiling water infusion or boiled water.
Example 2
Step 1: preparing 0.3-2mm rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, and rhizoma Smilacis Glabrae composite powder
Screening and weighing 3.6kg of clean rhizoma polygonati, 13.2kg of cyclocarya paliurus, 10.4kg of dried orange peel, 3.4kg of astragalus membranaceus, 3.6kg of medlar and 3.8kg of rhizoma smilacis glabrae, sterilizing at the temperature of 100 ℃ for 30 minutes in a hot air drying facility, adjusting the drying temperature to 77 ℃ for hot air drying, cooling after drying, crushing by a stainless steel crusher to obtain 0.3-2mm of compound powder of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and rhizoma smilacis glabrae, and carrying out compound crushing with the compound powder of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and rhizoma smilacis glabrae below 0.3 mm.
Step 2: preparing concentrated extract of rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, and rhizoma Smilacis Glabrae with size of less than 0.3mm
Placing 1.9kg of the composite powder of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus, medlar and glabrous greenbrier rhizome which are obtained by crushing in the step 1 into a cloth bag, placing into an extraction tank, adding 15.2kg of food water, extracting for 2 hours at the water temperature of 70 ℃, and filtering for the first time to obtain a first filtrate and a first filter residue; placing the first filter residue and the filter residue into an extraction tank, adding 15.2kg of food water, extracting at 70deg.C for 3 hr, and filtering for the second time to obtain the second filtrate.
Mixing the first filtrate and the second filtrate, adding into vacuum concentration tank, vacuum concentrating under vacuum concentration pressure of-0.092 MPa at 51deg.C, vacuum concentrating the filtrate until the concentration of the filtrate is about 17 with refractometer to obtain concentrated extract of rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae.
Step 3: preparing composite solution of ferric citrate, potassium citrate, rhizoma Polygonati, ramulus et folium Desmodii Styracifolii, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae
Weighing 0.2kg of ferric citrate and 1.8kg of potassium citrate, adding the concentrated extract of the sealwort, the cyclocarya paliurus, the dried orange peel, the astragalus membranaceus, the medlar and the glabrous greenbrier rhizome which are prepared in the step 2 and below 0.3mm, and boiling and dissolving uniformly to obtain the ferric citrate, potassium citrate, sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and glabrous greenbrier rhizome composite solution.
Step 4: preparation of rhizoma polygonati and medlar tea
Adding the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and smilax glabra prepared in the step 1 into a clean container or mixing equipment, uniformly spraying the ferric citrate, potassium citrate, sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and smilax glabra prepared in the step 3 into the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and smilax glabra prepared in the step 1, fully and uniformly mixing, adding a stainless steel plate, drying at 75 ℃ by hot air, cooling after drying, packaging into 10 g of each part by using a heat-seal food-grade tea bag and a food packaging bag, and soaking the mixture into boiled water for drinking or boiling the sealwort medlar tea.
Example 3
Step 1: preparing 0.3-2mm rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, and rhizoma Smilacis Glabrae composite powder
Screening and weighing 1.8kg of clean rhizoma polygonati, 6.6kg of cyclocarya paliurus, 5.2kg of dried orange peel, 1.7kg of astragalus membranaceus, 1.8kg of medlar and 1.9kg of rhizoma smilacis glabrae, sterilizing at the temperature of 100 ℃ for 30 minutes in a hot air drying facility, adjusting the drying temperature to 73 ℃ for hot air drying, cooling after drying, crushing by a stainless steel crusher to obtain 0.3-2mm of compound powder of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and rhizoma smilacis glabrae, and carrying out compound crushing with the compound powder of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and rhizoma smilacis glabrae below 0.3 mm.
Step 2: preparing concentrated extract of rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, and rhizoma Smilacis Glabrae with size of less than 0.3mm
Placing 0.95kg of the composite powder of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and glabrous greenbrier rhizome which are obtained by crushing in the step 1 into a cloth bag, placing into an extraction tank, adding 5.7kg of edible alcohol with alcohol content of 45 degrees, extracting for 3 days at room temperature, and filtering for the first time to obtain a first filtrate and a first filter residue; placing the first filter residue into an extraction tank, adding 5.7kg of edible alcohol with alcohol content of 42 degrees, extracting at room temperature for 4 days, and filtering for the second time to obtain a second filtrate and a second filter residue; placing the second filter residue into an extraction tank, adding 5.7kg of edible alcohol with alcohol content of 40 degrees, extracting at room temperature for 5 days, and filtering for the third time to obtain a third filtrate.
Mixing the first filtrate, the second filtrate and the third filtrate, adding into vacuum alcohol recovery concentration tank, vacuum concentrating under vacuum concentration pressure of-0.091 MPa at 51deg.C, vacuum concentrating the filtrate until the concentration of the filtrate is about 19 with refractometer to obtain concentrated extract of rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae.
Step 3: preparing composite solution of ferric citrate, potassium citrate, rhizoma Polygonati, ramulus et folium Desmodii Styracifolii, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae
Weighing 0.1kg of ferric citrate and 0.9kg of potassium citrate, adding the concentrated extract of the sealwort, the cyclocarya paliurus, the dried orange peel, the astragalus membranaceus, the medlar and the glabrous greenbrier rhizome which are prepared in the step 2 and below 0.3mm, and boiling and dissolving uniformly to obtain the ferric citrate, potassium citrate, sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and glabrous greenbrier rhizome composite solution.
Step 4: preparation of rhizoma polygonati and medlar tea
Adding the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and smilax glabra prepared in the step 1 into a clean container or mixing equipment, uniformly spraying the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and smilax glabra prepared in the step 3 into the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and smilax glabra prepared in the step 1, fully and uniformly mixing, adding a 33cm multiplied by 57cm stainless steel plate of a vacuum drying oven, 2.75kg of each plate, vacuum pressure of-0.092 MPa and temperature of 52 ℃, vacuum drying, cooling after drying, packaging into heat-sealing food-grade tea bags and food packaging bags, and obtaining 10 g of each part of sealwort medlar tea which can be drunk by boiling water infusion or boiled water.
Example 4
Step 1: preparing 0.3-2mm rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, and rhizoma Smilacis Glabrae composite powder
Screening and weighing 3.6kg of clean rhizoma polygonati, 13.2kg of cyclocarya paliurus, 10.4kg of dried orange peel, 3.4kg of astragalus membranaceus, 3.6kg of medlar and 3.8kg of rhizoma smilacis glabrae, sterilizing at the temperature of 100 ℃ for 30 minutes in a hot air drying facility, adjusting the drying temperature to 77 ℃ for hot air drying, cooling after drying, crushing by a stainless steel crusher to obtain 0.3-2mm of compound powder of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and rhizoma smilacis glabrae, and carrying out compound crushing with the compound powder of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and rhizoma smilacis glabrae below 0.3 mm.
Step 2: preparing concentrated extract of rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, and rhizoma Smilacis Glabrae with size of less than 0.3mm
Placing 1.9kg of the composite powder of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and glabrous greenbrier rhizome which are obtained by crushing in the step 1 into a cloth bag, placing into an extraction tank, adding 15.2kg of edible alcohol with the alcohol content of 45 degrees, extracting for 3 days at room temperature, and filtering for the first time to obtain a first filtrate and a first filter residue; placing the first filter residue into an extraction tank, adding 15.2kg of edible alcohol with alcohol content of 42 degrees, extracting at room temperature for 5 days, and filtering for the second time to obtain a second filtrate.
Mixing the first filtrate and the second filtrate, adding into vacuum alcohol recovery concentration tank, vacuum concentrating under vacuum concentration pressure of-0.092 MPa at 51deg.C, vacuum concentrating the filtrate until the concentration of the filtrate is about 19 with refractometer to obtain concentrated extract of rhizoma Polygonati, ramulus Salicis Babylonicae, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, and rhizoma Smilacis Glabrae.
Step 3: preparing composite solution of ferric citrate, potassium citrate, rhizoma Polygonati, ramulus et folium Desmodii Styracifolii, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae
Weighing 0.2kg of ferric citrate and 1.8kg of potassium citrate, adding the concentrated extract of the sealwort, the cyclocarya paliurus, the dried orange peel, the astragalus membranaceus, the medlar and the glabrous greenbrier rhizome which are prepared in the step 2 and below 0.3mm, and boiling and dissolving uniformly to obtain the ferric citrate, potassium citrate, sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and glabrous greenbrier rhizome composite solution.
Step 4: preparation of rhizoma polygonati and medlar tea
Adding the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and smilax glabra prepared in the step 1 into a clean container or mixing equipment, uniformly spraying the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and smilax glabra prepared in the step 3 into the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus membranaceus, medlar and smilax glabra prepared in the step 1, fully and uniformly mixing, adding a stainless steel plate, drying at the drying temperature of 76 ℃ by hot air, cooling after drying, packaging into 6 g of each part by using a heat-seal food-grade tea bag and a food packaging bag, and soaking the mixture into boiled water or boiling the sealwort medlar tea.
The foregoing description of the preferred embodiments of the invention is not intended to limit the invention to the precise form disclosed, and any such modifications, equivalents, and alternatives falling within the spirit and scope of the invention are intended to be included within the scope of the invention.
The materials used in the present invention are common raw materials known to those skilled in the art for food processing.
Other specific conditions and equipment, etc. employed in the present invention are known to those skilled in the art.
The raw materials used in the embodiment of the invention respectively accord with corresponding standard and specified raw materials.
The sealwort medlar tea provided by the invention is prepared by adopting the combination of raw materials of common food materials and medicines and foods, is carefully prepared based on the traditional process, is combined with modern technology and modern technology, is novel, can be used for four-high food recuperation, is nutritional and healthy sealwort medlar tea which is prepared by utilizing food, and is a healthy health tea drink which can be brewed and drunk by boiling water or boiled water.
The sealwort medlar tea provided by the invention is prepared from daily food materials and medicinal and edible raw materials scientifically, and has the advantages of simple and easily obtained food materials, health and nutrition, good taste, convenience and practicability and the like.
Although a sealwort medlar tea according to the present invention has been described in detail by way of the above preferred embodiments, it should be appreciated that the above description should not be construed as limiting the invention. Many modifications and substitutions of the present invention will become apparent to those of ordinary skill in the art upon reading the foregoing. Accordingly, the scope of the invention should be limited only by the attached claims.
Claims (10)
1. A preparation method of sealwort medlar tea is characterized by comprising the following steps:
step 1: preparing 0.3-2mm rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, and rhizoma Smilacis Glabrae composite powder
Screening and weighing clean rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae, sterilizing with hot air drying facility, hot air drying, and crushing with stainless steel crusher to obtain 0.3-2mm rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae composite powder, and mixing with rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae composite powder below 0.3 mm;
step 2: preparing concentrated extract of rhizoma Polygonati, ramulus et folium Tamaricis, pericarpium Citri Tangerinae, radix astragali, fructus Lycii, and rhizoma Smilacis Glabrae with size of less than 0.3mm
Placing the crushed composite powder of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus, medlar and smilax glabra obtained in the step 1 into a cloth bag, and extracting at room temperature or heating to obtain extract of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus, medlar and smilax glabra with the size of less than 0.3mm, and concentrating the extract in vacuum to obtain concentrated extract of rhizoma polygonati, cyclocarya paliurus, dried orange peel, astragalus, medlar and smilax glabra;
step 3: preparing composite solution of ferric citrate, potassium citrate, rhizoma Polygonati, ramulus et folium Desmodii Styracifolii, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae
Weighing ferric citrate and potassium citrate, adding the concentrated extract of rhizoma polygonati, cyclocarya paliurus, dried orange peel, radix astragali, medlar and rhizoma smilacis glabrae which are prepared in the step 2 and below 0.3mm, and boiling and dissolving uniformly to obtain a ferric citrate, potassium citrate, rhizoma polygonati, cyclocarya paliurus, dried orange peel, radix astragali, medlar and rhizoma smilacis glabrae composite solution;
step 4: preparation of rhizoma polygonati and medlar tea
Adding the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus, medlar and glabrous greenbrier rhizome prepared in the step 1 into a clean container or mixing equipment, uniformly spraying the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus, medlar and glabrous greenbrier rhizome prepared in the step 3 into the compound solution of ferric citrate, potassium citrate, sealwort, cyclocarya paliurus, dried orange peel, astragalus, medlar and glabrous greenbrier rhizome prepared in the step 1, fully and uniformly mixing, and carrying out vacuum drying or hot air drying; packaging into 6-10 g of heat-sealed food-grade tea bag and food packaging bag, and soaking with boiling water or boiling water to obtain rhizoma Polygonati and fructus Lycii tea.
2. The method for preparing a sealwort medlar tea according to claim 1, wherein in step 1, sealwort, cyclocarya paliurus, dried orange peel, astragalus, medlar and glabrous greenbrier rhizome are weighed and screened; sterilizing at 100deg.C for 30 min, drying at 70-80deg.C, cooling, and pulverizing into composite powder.
3. The method for preparing a tea of Polygonatum sibiricum and Lycium barbarum according to claim 1, wherein in step 2, the extract is concentrated in vacuum at a vacuum concentration pressure of-0.088 MPa to-0.092 MPa and a temperature of 48 ℃ to 55 ℃.
4. The method according to claim 1, wherein in step 2, the extraction is performed at room temperature or at a temperature.
5. The preparation method of the sealwort medlar tea according to claim 1, wherein in the step 2, the specific method of room temperature extraction is as follows: placing the rhizoma polygonati, the cyclocarya paliurus, the dried orange peel, the astragalus, the medlar and the smilax glabra composite powder which are obtained after crushing in the step 1 into a cloth bag, adding the rhizoma polygonati, the cyclocarya paliurus, the dried orange peel, the astragalus, the medlar and the smilax glabra composite powder which are obtained after crushing in the step 1, and extracting the rhizoma polygonati, the cyclocarya paliurus, the dried orange peel, the astragalus, the medlar and the smilax glabra composite powder with the alcoholic strength of 40-45 degrees, which is 6-8 times of the weight of the rhizoma polygonati, the cyclocarya paliurus, the dried orange peel and the smilax glabra composite powder, at room temperature for 3-5 days each time for 2-3 times;
the specific method for heating extraction comprises the following steps: placing the rhizoma polygonati, the cyclocarya paliurus, the dried orange peel, the astragalus, the medlar and the smilax glabra composite powder which are obtained by crushing in the step 1 into a cloth bag, adding 6-8 times of edible water by weight of the rhizoma polygonati, the cyclocarya paliurus, the dried orange peel, the astragalus, the medlar and the smilax glabra composite powder which are obtained by crushing in the step 1, and extracting at the temperature of 70 ℃ for 2-3 hours each time for 2-3 times.
6. The method according to claim 1, wherein in step 2, the extract is filtered by a filter cloth, and the filtrate is added into a vacuum concentration tank, and vacuum concentration is carried out at a vacuum concentration pressure of-0.088 MPa to-0.092 MPa and a temperature of 48 ℃ to 55 ℃ until the concentration of the filtrate is 15 to 20 by a refractometer.
7. The method for preparing a sealwort medlar tea according to claim 1, wherein in step 3, the compound solution: weighing ferric citrate and potassium citrate, adding the concentrated extract of rhizoma Polygonati, ramulus et folium Salicis Babylonicae, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae with the size of less than 0.3mm prepared in step 2, boiling, stirring, and dissolving uniformly to obtain ferric citrate, potassium citrate, rhizoma Polygonati, ramulus et folium Salicis Babylonicae, pericarpium Citri Tangerinae, radix astragali, fructus Lycii and rhizoma Smilacis Glabrae composite solution.
8. The method of claim 1, wherein in step 4, the tea is dried by vacuum or hot air.
9. The method for preparing the sealwort medlar tea according to claim 1, wherein in the step 4, the specific method for vacuum drying is as follows: adding the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus, medlar and glabrous greenbrier rhizome prepared in the step 1 into a clean container or mixing equipment, uniformly spraying the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus, medlar and glabrous greenbrier rhizome prepared in the step 3 into the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus, medlar and glabrous greenbrier rhizome prepared in the step 1, fully and uniformly mixing, adding a stainless steel plate of a vacuum drying box, and vacuum drying under the vacuum drying pressure of-0.089 MPa to-0.094 MPa and the temperature of 48-55 ℃.
The hot air drying method specifically comprises the following steps: adding the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus, medlar and glabrous greenbrier rhizome prepared in the step 1 into a clean container or mixing equipment, uniformly spraying the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus, medlar and glabrous greenbrier rhizome prepared in the step 3 into the 0.3-2mm sealwort, cyclocarya paliurus, dried orange peel, astragalus, medlar and glabrous greenbrier rhizome prepared in the step 1, fully and uniformly mixing, adding a stainless steel plate, and drying with hot air at the drying temperature of 70-80 ℃.
10. The preparation method of the sealwort medlar tea according to claim 1, wherein in the step 4, the sealwort, the cyclocarya paliurus, the dried orange peel, the astragalus, the medlar and the smilax glabra which are prepared in the step 1 are compositely crushed, the clean container or the mixing equipment is added, the ferric citrate, the potassium citrate, the sealwort, the cyclocarya paliurus, the dried orange peel, the astragalus, the medlar and the smilax glabra which are prepared in the step 3 are compositely crushed, and the solution is uniformly sprayed on the sealwort, the cyclocarya paliurus, the dried orange peel, the astragalus, the medlar and the smilax glabra which are prepared in the step 1, fully and uniformly mixed, and dried in vacuum or dried by hot air; packaging into 6-10 g of heat-sealed food-grade tea bag and food packaging bag, and soaking with boiling water or boiling water to obtain rhizoma Polygonati and fructus Lycii tea.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311331877.4A CN117256708A (en) | 2023-10-15 | 2023-10-15 | Polygonatum sibiricum and wolfberry tea and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311331877.4A CN117256708A (en) | 2023-10-15 | 2023-10-15 | Polygonatum sibiricum and wolfberry tea and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117256708A true CN117256708A (en) | 2023-12-22 |
Family
ID=89205998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311331877.4A Pending CN117256708A (en) | 2023-10-15 | 2023-10-15 | Polygonatum sibiricum and wolfberry tea and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117256708A (en) |
-
2023
- 2023-10-15 CN CN202311331877.4A patent/CN117256708A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102669667B (en) | Health food with dual functions of protecting liver and adjusting blood fat and preparation method thereof | |
| CN102763884B (en) | Health-care beverage of guava and making method of health-care beverage | |
| CN107296949A (en) | Integration of drinking and medicinal herbs compound formulation and its preparation method and application | |
| CN104366636A (en) | Gynura procumbens compound preparation as well as preparation method and application thereof | |
| CN103609992B (en) | Preparation method of Korean red ginseng cream | |
| CN103891963A (en) | Health tea with effects of reducing blood pressure, reducing blood fat and decreasing blood sugar and preparation method of health tea | |
| KR100451665B1 (en) | making method of health food, the chief ingredient is carthamus tinctorius seed, and the health food | |
| CN107822040A (en) | A kind of preparation method of rhizoma zingiberis cinnamon health care jelly | |
| CN103230064A (en) | Hawthorn compound beverage | |
| CN108096502B (en) | Uric acid-reducing substitutional tea and preparation method thereof | |
| CN105029421A (en) | Health care product for conditioning phlegm-dampness constitution | |
| CN108066712A (en) | A kind of benefiting qi and nourishing blood Chinese medicine composition | |
| CN101385536A (en) | Natural plant hypoglycemic effervescent beverages | |
| CN108904697A (en) | A kind of female irregular menstruation conditioning cream and preparation method thereof | |
| CN110583974A (en) | Slimming whole grain nutritional and healthy meal replacement food and preparation method thereof | |
| CN117256708A (en) | Polygonatum sibiricum and wolfberry tea and preparation method thereof | |
| CN102526537A (en) | Medicinal composition for treating hyperglycemia | |
| CN106362067A (en) | Roxburg rose fruit appetite improving and digestion promoting drug composition and preparation method thereof | |
| KR20110025454A (en) | Functional food and method of preparing thereof | |
| CN105211418A (en) | Health tea electuary of a kind of bushing and preparation method thereof | |
| CN105394279A (en) | Lipid-decreasing and weight-losing tea with traditional Chinese medicine added and preparation method of tea | |
| CN104606571A (en) | Fresh spinach root tea substituted drink with effects of helping produce saliva and slaking thirst and preparation method thereof | |
| CN105028832A (en) | Blueberry tea capable of alleviating fatigue of eyes and preparation method of blueberry tea | |
| CN104922504A (en) | Vinegar beverage for treating atherosclerosis and preparation method thereof | |
| CN109170052A (en) | A kind of dendrobium nobile stomach-nourishing health tea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication |